Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works matching IS 09147187 AND DT 2020 AND VI 34 AND IP 12
Results: 12
1
2
The quantification of PET–CT radiotracers to determine minimal scan time using quadratic formulation.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 884, doi. 10.1007/s12149-020-01543-x
- By:
- Publication type:
- Article
3
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 968, doi. 10.1007/s12149-020-01539-7
- By:
- Publication type:
- Article
4
Value of 18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 911, doi. 10.1007/s12149-020-01536-w
- By:
- Publication type:
- Article
5
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 932, doi. 10.1007/s12149-020-01529-9
- By:
- Publication type:
- Article
6
Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 960, doi. 10.1007/s12149-020-01527-x
- By:
- Publication type:
- Article
7
Comparison of diagnostic accuracy between [18F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 952, doi. 10.1007/s12149-020-01526-y
- By:
- Publication type:
- Article
8
Metabolic changes in breast cancer on dual-time-point 18F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 942, doi. 10.1007/s12149-020-01525-z
- By:
- Publication type:
- Article
9
The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 926, doi. 10.1007/s12149-020-01524-0
- By:
- Publication type:
- Article
10
Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 920, doi. 10.1007/s12149-020-01523-1
- By:
- Publication type:
- Article
11
Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 899, doi. 10.1007/s12149-020-01522-2
- By:
- Publication type:
- Article
12
Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions.
- Published in:
- Annals of Nuclear Medicine, 2020, v. 34, n. 12, p. 892, doi. 10.1007/s12149-020-01520-4
- By:
- Publication type:
- Article